Zepbound Clinical Trial Findings - Search News

News

Zepbound beats Wegovy for weight loss

Associated Press News on MSN · 2d

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head trial of the blockbuster weight-loss medications.

Becker's Hospital Review · 1d

Zepbound beats Wegovy for weight loss: Study

Eli Lilly’s weight loss drug Zepbound led to significantly greater weight loss than Novo Nordisk’s Wegovy in a 72-week, head-to-head clinical trial, according to findings published in The New England Journal of Medicine and presented at the European Congress on Obesity.

New Atlas · 1d

Dual-target weight-loss drug is 47% more effective than its rival

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference. And one clearly comes out on top.

2d

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

2don MSN

Lilly’s Zepbound Trims More Belly Fat Than Novo’s Wegovy

Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results